These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 9307284

  • 1. Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter.
    He Y, Huang L.
    Cancer Res; 1997 Sep 15; 57(18):3993-9. PubMed ID: 9307284
    [Abstract] [Full Text] [Related]

  • 2. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth AB.
    Cancer Gene Ther; 1995 Mar 15; 2(1):19-32. PubMed ID: 7621252
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of E7 antisense RNA-induced antitumor immunity by co-delivery of IL-12 gene in HPV16 DNA-positive mouse tumor.
    He YK, Lui VW, Baar J, Wang L, Shurin M, Almonte C, Watkins SC, Huang L.
    Gene Ther; 1998 Nov 15; 5(11):1462-71. PubMed ID: 9930299
    [Abstract] [Full Text] [Related]

  • 4. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
    Choo CK, Ling MT, Suen CK, Chan KW, Kwong YL.
    Gynecol Oncol; 2000 Sep 15; 78(3 Pt 1):293-301. PubMed ID: 10985883
    [Abstract] [Full Text] [Related]

  • 5. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N, Wang S, Wang W, Kong D, Xu Q, Tian X, Luo A, Zhou J, Xu G, Meng L, Lu Y, Ma D.
    Gynecol Oncol; 2007 Aug 15; 106(2):299-304. PubMed ID: 17586029
    [Abstract] [Full Text] [Related]

  • 6. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells.
    Hamada K, Sakaue M, Alemany R, Zhang WW, Horio Y, Roth JA, Mitchell MF.
    Gynecol Oncol; 1996 Nov 15; 63(2):219-27. PubMed ID: 8910631
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
    Hamada K, Shirakawa T, Gotoh A, Roth JA, Follen M.
    Gynecol Oncol; 2006 Dec 15; 103(3):820-30. PubMed ID: 16908054
    [Abstract] [Full Text] [Related]

  • 8. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
    Fujii T, Saito M, Iwasaki E, Ochiya T, Takei Y, Hayashi S, Ono A, Hirao N, Nakamura M, Kubushiro K, Tsukazaki K, Aoki D.
    Int J Oncol; 2006 Sep 15; 29(3):541-8. PubMed ID: 16865269
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes.
    Tan TM, Ting RC.
    Cancer Res; 1995 Oct 15; 55(20):4599-605. PubMed ID: 7553636
    [Abstract] [Full Text] [Related]

  • 10. [Reversal effect of antisense RNA targeting human papillomavirus 16 (HPV16) E6E7 on malignancy of human cervical cancer cell line SiHa].
    Sima N, Wang W, Xu Q, Tian X, Luo AY, Lu YP, Wang SX, Ma D.
    Ai Zheng; 2007 Jan 15; 26(1):26-31. PubMed ID: 17222363
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The early genes E6 and E7 of cancer associated human papilloma viruses as targets of tumor suppression?
    Bosch FX, Dürst M, Schwarz E, Boukamp P, Fusenig NE, zur Hausen H.
    Behring Inst Mitt; 1991 Jul 15; (89):108-21. PubMed ID: 1656929
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K, Whitaker N, Denk C, Ullmann A, Geisen C, Hoppe-Seyler F.
    Oncogene; 1999 Apr 08; 18(14):2381-6. PubMed ID: 10327059
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.
    Stabile LP, Lyker JS, Huang L, Siegfried JM.
    Gene Ther; 2004 Feb 08; 11(3):325-35. PubMed ID: 14737093
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning GL.
    Cancer; 2002 Apr 15; 94(8):2199-210. PubMed ID: 12001118
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T, Sasaki C, Weinberger P, Psyrri A.
    J Natl Cancer Inst; 2009 Mar 18; 101(6):412-23. PubMed ID: 19276448
    [Abstract] [Full Text] [Related]

  • 20. [The biological activities of the human papillomavirus type 16 E6/E7 cDNAs cloned from the SiHa cervical carcinoma cell line].
    Tamada Y.
    Hokkaido Igaku Zasshi; 1993 Nov 18; 68(6):849-61. PubMed ID: 8112710
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.